PREVENTION OF SUDDEN CARDIAC DEATH BY IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS: ANALYSIS OF LARGE-SCALE CLINICAL TRIALS AND RECOMMENDATIONS OF EUROPEAN SOCIETY OF CARDIOLOGY (2015)

The frequency of sudden cardiac death remains still high, globally every year 3 mln. people suddenly die. During last thirty years it has been possible to prevent sudden cardiac death by using implantable cardioverter-defibrillators. For all this time the number of large clinical trials has been con...

Full description

Bibliographic Details
Main Author: N. V. Melnik
Format: Article
Language:Russian
Published: New Terra Publishing House 2018-01-01
Series:Вестник анестезиологии и реаниматологии
Subjects:
Online Access:https://www.vair-journal.com/jour/article/view/152
Description
Summary:The frequency of sudden cardiac death remains still high, globally every year 3 mln. people suddenly die. During last thirty years it has been possible to prevent sudden cardiac death by using implantable cardioverter-defibrillators. For all this time the number of large clinical trials has been conducted confirming the improved survival when using implantable cardioverter-defibrillators. The last edition of Guidelines for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death was presented by European Society of Cardiology in 2015. However there are a lot of unsolved problems first of all related to indications for implantation of cardioverter-defibrillators. This review analyzes the existing evidences and depicts the current use of implantable cardioverter-defibrillators in the clinical practice.
ISSN:2078-5658
2541-8653